<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9D2EFD3F-784E-4E53-9F64-5D804BA83F06"><gtr:id>9D2EFD3F-784E-4E53-9F64-5D804BA83F06</gtr:id><gtr:name>HAEMAIR LTD</gtr:name><gtr:address><gtr:line1>ROOM 403 ILS PHASE 2</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5CB0D63B-413D-4D04-B84A-269434C8C818"><gtr:id>5CB0D63B-413D-4D04-B84A-269434C8C818</gtr:id><gtr:name>Heart and Diabetes Centre North Rhine-Westphalia (HDZ NRW)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB307619-D4FA-427E-A042-09DBEBA84669"><gtr:id>AB307619-D4FA-427E-A042-09DBEBA84669</gtr:id><gtr:name>Swansea University</gtr:name><gtr:address><gtr:line1>Singleton Park</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9D2EFD3F-784E-4E53-9F64-5D804BA83F06"><gtr:id>9D2EFD3F-784E-4E53-9F64-5D804BA83F06</gtr:id><gtr:name>HAEMAIR LTD</gtr:name><gtr:address><gtr:line1>ROOM 403 ILS PHASE 2</gtr:line1><gtr:postCode>SA2 8PP</gtr:postCode><gtr:region>Wales</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5CB0D63B-413D-4D04-B84A-269434C8C818"><gtr:id>5CB0D63B-413D-4D04-B84A-269434C8C818</gtr:id><gtr:name>Heart and Diabetes Centre North Rhine-Westphalia (HDZ NRW)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6CD3EFA0-29D0-4047-A2C7-0F89824553BF"><gtr:id>6CD3EFA0-29D0-4047-A2C7-0F89824553BF</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:otherNames>Ann</gtr:otherNames><gtr:surname>Thornton</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_13039"><gtr:id>E7A3CC26-C6B6-44A9-B4F1-77FA083618F1</gtr:id><gtr:title>Biomedical Catalyst ? Demonstration of a low cost implantable blood pump</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_PC_13039</gtr:grantReference><gtr:abstractText>Advanced heart failure is a large and growing healthcare challenge not adequately met by traditional medical management, cardiac resynchronisation or transplantation. Ventricular assist devices (VADs) can address this need and have shown very promising clinical results. 
However, existing VADs are expensive, have high utilisation costs due to significant complications and require extensive invasive surgery for implantation. Calon?s MiniVAD addresses these problems with a smaller pump, reduced blood damage and significantly improved health economics. 
This project proposes the development of novel blood damage assays and the subsequent detailed in-vitro and in-vivo evaluation of the MiniVAD to provide the performance and safety data necessary to support a regulatory application to begin human clinical studies.</gtr:abstractText><gtr:technicalSummary>Advanced heart failure is a large and growing healthcare challenge not adequately met by traditional medical management, cardiac resynchronisation or transplantation. Ventricular assist devices (VADs) can address this need and have shown very promising clinical results. 
However, existing VADs are expensive, have high utilisation costs due to significant complications and require extensive invasive surgery for implantation. Calon?s MiniVAD addresses these problems with a smaller pump, reduced blood damage and significantly improved health economics. 
This project proposes the development of novel blood damage assays and the subsequent detailed in-vitro and in-vivo evaluation of the MiniVAD to provide the performance and safety data necessary to support a regulatory application to begin human clinical studies.</gtr:technicalSummary><gtr:fund><gtr:end>2015-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Haemair Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Optimised assay development for blood health in transfusion settings</gtr:description><gtr:id>A7F40A47-015F-45A9-9CAE-008586D2D5E5</gtr:id><gtr:impact>A grant application to SMARTExpertise, Welsh Government (SMARTBlood)is in preparation</gtr:impact><gtr:outcomeId>58c6b936a70a04.27513271-1</gtr:outcomeId><gtr:partnerContribution>The company provides the devices for testing, staff to run the assays once developed, and undertake all experimental work and data analysis</gtr:partnerContribution><gtr:piContribution>We have developed a red blood cell fragility assay for flow cytometry which is now in use by the company; we are progressing to cytokine assays of fluid phase.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heart and Diabetes Centre North Rhine-Westphalia (HDZ NRW)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Erasumus+ Staff Mobility</gtr:description><gtr:id>9C29A8AE-560E-4DD0-B893-274AB2A14662</gtr:id><gtr:impact>This collaboation is in its early stages but we are targeting Horizon 2020 submission in 2015.</gtr:impact><gtr:outcomeId>545cd154e4c0e5.97632657-1</gtr:outcomeId><gtr:partnerContribution>The partners will provide some training but also plasma samples from patients who have been implanted with ventricular assist devices, and explanted devices.</gtr:partnerContribution><gtr:piContribution>Dr Pieper, the post-doctoral researcher on the project has been awarded an Erasmus+ staff mobility award to travel to Professor Hendrik Milting's laboratory and undertake training as a prelude to exchange of samples and methodologies.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>SoapBox Science</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>48764CF1-4A36-4C82-AE81-FD628097D4C3</gtr:id><gtr:impact>Participated in SoapBox Science, Swansea</gtr:impact><gtr:outcomeId>58c6bd9f7f28e8.35115885</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2981</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Seed corn grants</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>St. David's Medical Foundation</gtr:fundingOrg><gtr:id>7AC8B87F-20A5-484E-8AA6-B110FDACE800</gtr:id><gtr:outcomeId>56d99ca21296d5.98358269</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2157</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Impact Acceleration Account</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>47192B18-82F8-4FEE-95B8-506A16EB537D</gtr:id><gtr:outcomeId>56d99ac0e28741.97732508</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8EE52E68-69DE-491F-9128-CE85C504E43A</gtr:id><gtr:title>Ovine Leukocyte Microparticles Generated by the CentriMag Ventricular Assist Device In Vitro.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fc9b3351de4e6a1d9c12d50be7641e5"><gtr:id>3fc9b3351de4e6a1d9c12d50be7641e5</gtr:id><gtr:otherNames>Pieper IL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>5aa6d575cd4123.28197935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10193DA5-83E2-4E94-ABE0-6CABC132AB83</gtr:id><gtr:title>Evaluation of Four Veterinary Hematology Analyzers for Bovine and Ovine Blood Counts for In Vitro Testing of Medical Devices.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fc9b3351de4e6a1d9c12d50be7641e5"><gtr:id>3fc9b3351de4e6a1d9c12d50be7641e5</gtr:id><gtr:otherNames>Pieper IL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>56dda1c045add0.99240062</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DD6C19D-CC3B-4BD4-A882-B9CBE3C1E968</gtr:id><gtr:title>The effect of shear stress on the size, structure, and function of human von Willebrand factor.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bd5afe1c5d7b6d1a01cbdb21a4800c"><gtr:id>31bd5afe1c5d7b6d1a01cbdb21a4800c</gtr:id><gtr:otherNames>Chan CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>545cb2c6b51219.81553333</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F34668FC-A64F-4AD3-8BCC-FAA0ED2D2459</gtr:id><gtr:title>Isolation of Mesenchymal Stromal Cells From Peripheral Blood of ST Elevation Myocardial Infarction Patients.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fc9b3351de4e6a1d9c12d50be7641e5"><gtr:id>3fc9b3351de4e6a1d9c12d50be7641e5</gtr:id><gtr:otherNames>Pieper IL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>58c6bcb22783d0.26852817</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A7792B1-4026-4111-A01F-B36D06F9E6D3</gtr:id><gtr:title>The effect of ventricular assist device-associated biomaterials on human blood leukocytes.</gtr:title><gtr:parentPublicationTitle>Journal of biomedical materials research. Part B, Applied biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03924d6fcab1210360f0cddff42c5a7c"><gtr:id>03924d6fcab1210360f0cddff42c5a7c</gtr:id><gtr:otherNames>Radley G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1552-4973</gtr:issn><gtr:outcomeId>5aa6d5760c9892.88152486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3DCD2085-5C98-43D6-81FC-51EE4092F3C7</gtr:id><gtr:title>Shear Stress-Induced Total Blood Trauma in Multiple Species.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cac33929edd31c49cebc2ca1bcb186f5"><gtr:id>cac33929edd31c49cebc2ca1bcb186f5</gtr:id><gtr:otherNames>Chan CHH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>5aa6d5765ec160.49636022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EBC8D46-B6C5-427E-A7F4-63761E1F46BC</gtr:id><gtr:title>The evaluation of leukocytes in response to the in vitro testing of ventricular assist devices.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bd5afe1c5d7b6d1a01cbdb21a4800c"><gtr:id>31bd5afe1c5d7b6d1a01cbdb21a4800c</gtr:id><gtr:otherNames>Chan CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>545cb2c711b539.97237695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BE0C6EE-4C32-4043-BA08-FF7DABD38A7A</gtr:id><gtr:title>The CentriMag centrifugal blood pump as a benchmark for in vitro testing of hemocompatibility in implantable ventricular assist devices.</gtr:title><gtr:parentPublicationTitle>Artificial organs</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31bd5afe1c5d7b6d1a01cbdb21a4800c"><gtr:id>31bd5afe1c5d7b6d1a01cbdb21a4800c</gtr:id><gtr:otherNames>Chan CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0160-564X</gtr:issn><gtr:outcomeId>545cb2c6ddd5d6.27822998</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_13039</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93E3E424-8678-4BDD-9675-2EA16B3EFEA4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>5.3  Medical devices</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>